Anti-mycobacterial compound from an endangered medicinal plant Curcuma aeruginosa and identification of its probable targets using in silico method Online publication date: Mon, 21-Mar-2022
by Sneha Manthattil Vysyan; Arun Kumar Gangadharan; Sujina Kappadan; Sadasivan Chittalakkottu
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 14, No. 6, 2021
Abstract: Due to the development of multi-drug resistance, tuberculosis, a re-emerged deadly disease demands novel therapeutics. In the present study, antimycobacterial phytochemicals were screened from medicinally and traditionally valued plants. Plants were extracted with different solvents and growth inhibition potential of the extract was evaluated against Mycobacterium smegmatis, an often used model in tubercular studies. The ethyl acetate fraction of Curcuma aeruginosa was found to inhibit the growth of the organism and hence it was further purified. The LC-MS characterisation of the extract showed that the active compound might be curcumenone. To identify the possible targets, in silico docking studies were carried out against ten selected enzymes, involved in the pathways of cell wall formation, mycolic acid, nucleic acid and amino acid synthesis and energy metabolism of Mycobacterium tuberculosis.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook